Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter s Revenues Up, Earnings Down in Q1

NEW YORK, May 3 (GenomeWeb News) - Beckman Coulter reported increased revenues but smaller earnings for the first quarter of 2004 today.

 

The company had $536.8 million in revenues, up from $467.3 million during the first quarter last year.

 

R&D expenses increased to $48.1 million, from $45.5 million during the same period in 2003.

 

Net earnings decreased to $35.6 million, or $.57 per share, down from $44.6 million, or $.73 per share, during the first quarter last year.

 

As of March 31, Beckman had $49 million in cash and cash equivalents.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more